EPISODE · May 19, 2022 · 12 MIN
Immunotherapy in HNSCC Series: Ep 3 - Role of the Medical Oncologist
from IMPACT Medicom · host IMPACT Medicom
In this episode of IMPACT Medicom’s podcast series on immunotherapies in Head and Neck Squamous Cell Carcinoma, we discuss the medical oncologist’s role in managing patients with HNSCC, and how immunotherapies fit in to their practice.Our Guest:Dr. Martin Smoragiewicz is a Medical Oncologist at the Odette Cancer Centre, part of Sunnybrook Health Sciences Centre in Toronto, Ontario. His clinical expertise is in Genitourinary and Head & Neck cancers and his research focuses on improving therapeutics, with a special interest in immunotherapy. Dr. Smoragiewicz is the principal investigator on numerous clinical trials, and the lead for Head & Neck clinical trials at the Odette Cancer Centre.This podcast episode was sponsored by Merck Canada.If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
Embed this episode
What this episode covers
In this episode of IMPACT Medicom’s podcast series on immunotherapies in Head and Neck Squamous Cell Carcinoma, we discuss the medical oncologist’s role in managing patients with HNSCC, and how immunotherapies fit in to their practice. Our Guest: Dr. Martin Smoragiewicz is a Medical Oncologist at the Odette Cancer Centre, part of Sunnybrook Health Sciences Centre in Toronto, Ontario. His clinical expertise is in Genitourinary and Head & Neck cancers and his research focuses on improving ...
Ready to play
Immunotherapy in HNSCC Series: Ep 3 - Role of the Medical Oncologist
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.